Literature DB >> 9767498

Intra-abdominal manifestations of Henoch-Schönlein purpura.

C K Choong1, S W Beasley.   

Abstract

Gastrointestinal involvement occurs in approximately two thirds of children with Henoch-Schönlein Purpura (HSP) and usually is manifested by abdominal pain. Abdominal symptoms precede the typical purpuric rash of HSP in 14-36%; the symptoms may mimic an acute surgical abdomen and result in unnecessary laparotomy. Major complications of abdominal involvement develop in 4.6% (range 1.3-13.6%), of which intussusception is by far the most common. The intussusceptum is confined to the small bowel in 58%; its frequent inaccessibility to demonstration by contrast enema means that ultrasonography is the investigation of choice. Ultrasonography complements serial clinical assessment, clarifies the nature of the gastrointestinal involvement and reduces the likelihood of unnecessary surgery. Bowel ischaemia and infarction, intestinal perforation, fistula formation, late ileal stricture, acute appendicitis, massive upper gastrointestinal haemorrhage, pancreatitis, hydrops of the gallbladder and pseudomembranous colitis are seen infrequently. Earlier diagnosis and prompt treatment of intra-abdominal complications has reduced the mortality from 40% to almost zero.

Entities:  

Mesh:

Year:  1998        PMID: 9767498     DOI: 10.1046/j.1440-1754.1998.00263.x

Source DB:  PubMed          Journal:  J Paediatr Child Health        ISSN: 1034-4810            Impact factor:   1.954


  30 in total

Review 1.  Ultrasound assessment of the bowel: inflammatory bowel disease and conditions beyond.

Authors:  Michael L Francavilla; Sudha A Anupindi; Summer L Kaplan; David M Biko
Journal:  Pediatr Radiol       Date:  2017-08-04

2.  Diagnostic value of plasma factor XIII in Henoch-Schönlein purpura.

Authors:  Kazunari Kaneko; Shiori Fujii; Tetsuo Shono; Yoshie Matsumoto; Naoto Arii; Ken-ichiro Kaneko
Journal:  Pediatr Nephrol       Date:  2004-03-31       Impact factor: 3.714

3.  Intussusception in children: lessons learned from intestinal lymphoma as a rare lead-point.

Authors:  H R Bussell; S Kroiss; S J Tharakan; M Meuli; U Moehrlen
Journal:  Pediatr Surg Int       Date:  2019-05-28       Impact factor: 1.827

4.  Necrosis of mesenteric lymph nodes in Henoch-Schönlein purpura.

Authors:  Pietro Ferrara; Donato Rigante; Antonio Leone; Claudia Orchi; Nadia Puma; Aurora Rossodivita; Emanuela Sacco; Pio Liberatore; Maria Elena Laino; Achille Stabile
Journal:  Rheumatol Int       Date:  2011-01-22       Impact factor: 2.631

5.  Hospitalization rates for intussusception in children aged 0-59 months from 2009 to 2014 in Italy.

Authors:  Vincenzo Restivo; Claudio Costantino; Fabio Tramuto; Francesco Vitale
Journal:  Hum Vaccin Immunother       Date:  2017-01-11       Impact factor: 3.452

6.  Differences in pathological characteristics and laboratory indicators in adult and pediatric patients with Henoch-Schönlein purpura nephritis.

Authors:  Zhi Liu; Yu-Dan Wei; Yue Hou; Ying Xu; Xiu-Jiang Li; Yu-Jun Du
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2016-10-18

7.  Acute appendicitis in Henoch-Schönlein purpura: a case report.

Authors:  Chan Jong Kim; Hae Yul Chung; So Youn Kim; Young Ok Kim; Seong Yeob Ryu; Jung Chul Kim; Jae Hun Chung
Journal:  J Korean Med Sci       Date:  2005-10       Impact factor: 2.153

Review 8.  Henoch-Schönlein purpura from vasculitis to intestinal perforation: A case report and literature review.

Authors:  Butsabong Lerkvaleekul; Suporn Treepongkaruna; Pawaree Saisawat; Pornsri Thanachatchairattana; Napat Angkathunyakul; Nichanan Ruangwattanapaisarn; Soamarat Vilaiyuk
Journal:  World J Gastroenterol       Date:  2016-07-14       Impact factor: 5.742

9.  Henoch-Schonlein purpura with intestinal perforation and cerebral hemorrhage: a case report.

Authors:  Hong-Liang Wang; Hai-Tao Liu; Qi Chen; Yang Gao; Kai-Jiang Yu
Journal:  World J Gastroenterol       Date:  2013-04-28       Impact factor: 5.742

Review 10.  Henoch-Schönlein purpura.

Authors:  Abraham Gedalia
Journal:  Curr Rheumatol Rep       Date:  2004-06       Impact factor: 4.592

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.